WallStreetZenWallStreetZen

NASDAQ: MTRY
Monterey Bio Acquisition Corp Stock

$10.56+0.06 (+0.57%)
Updated Jan 27, 2023
MTRY Price
$10.56
Fair Value Price
N/A
Market Cap
$51.68M
52 Week Low
$9.90
52 Week High
$10.65
P/E
-62.12x
P/B
-72.49x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$1.55M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-165.75
Operating Cash Flow
-$2M
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MTRY Overview

Monterey Bio Acquisition Corporation is a special purpose acquisition company (SPAC) formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the biotech industry. Monterey Bio Acquisition was incorporated in 2020 and is headquartered in New York, NY.

Zen Score

Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MTRY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MTRY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MTRY is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
MTRY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more MTRY due diligence checks available for Premium users.

Be the first to know about important MTRY news, forecast changes, insider trades & much more!

MTRY News

Valuation

MTRY fair value

Fair Value of MTRY stock based on Discounted Cash Flow (DCF)
Price
$10.56
Fair Value
$10.41
Overvalued by
1.46%
MTRY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MTRY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-62.12x
Industry
15.79x
Market
23.59x

MTRY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-72.49x
Industry
-34.04x

MTRY's financial health

Profit margin

Revenue
$0.0
Net Income
-$420.5k
Profit Margin
0%
MTRY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$117.5M
Liabilities
$118.2M
Debt to equity
-165.75
MTRY's short-term liabilities ($97.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTRY's long-term liabilities ($20.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTRY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MTRY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$121.3k
Investing
$0.0
Financing
$361.4k
MTRY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MTRY vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
MTRY$51.68M+0.57%-62.12x-72.49x
ADOC$51.54M0.00%-8.21x-11.98x
HHGC$52.36M-0.29%-4.66x-40.81x
BREZ$51.01M-0.09%19.56x-9.62x
PGRW$54.24M-0.36%1,029.00x-75.76x

Monterey Bio Acquisition Stock FAQ

What is Monterey Bio Acquisition's quote symbol?

NASDAQ: MTRY) Monterey Bio Acquisition trades on the NASDAQ under the ticker symbol MTRY. Monterey Bio Acquisition stock quotes can also be displayed as NASDAQ: MTRY.

If you're new to stock investing, here's how to buy Monterey Bio Acquisition stock.

What is the 52 week high and low for Monterey Bio Acquisition (NASDAQ: MTRY)?

(NASDAQ: MTRY) Monterey Bio Acquisition's 52-week high was $10.65, and its 52-week low was $9.90. It is currently -0.85% from its 52-week high and 6.67% from its 52-week low.

How much is Monterey Bio Acquisition stock worth today?

(NASDAQ: MTRY) Monterey Bio Acquisition currently has 4,894,384 outstanding shares. With Monterey Bio Acquisition stock trading at $10.56 per share, the total value of Monterey Bio Acquisition stock (market capitalization) is $51.68M.

Monterey Bio Acquisition stock was originally listed at a price of $10.12 in Oct 1, 2021. If you had invested in Monterey Bio Acquisition stock at $10.12, your return over the last 1 years would have been 4.35%, for an annualized return of 4.35% (not including any dividends or dividend reinvestments).

How much is Monterey Bio Acquisition's stock price per share?

(NASDAQ: MTRY) Monterey Bio Acquisition stock price per share is $10.56 today (as of Jan 27, 2023).

What is Monterey Bio Acquisition's Market Cap?

(NASDAQ: MTRY) Monterey Bio Acquisition's market cap is $51.68M, as of Jan 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Monterey Bio Acquisition's market cap is calculated by multiplying MTRY's current stock price of $10.56 by MTRY's total outstanding shares of 4,894,384.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.